Skip to content

Author

N. Ruhela

We have 2 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Multisystem toxicity signals of antibody–drug conjugates in solid tumors: A FAERS pharmacovigilance analysis, 2020–2025.

376 Background: Antibody-drug conjugates (ADCs) have transformed treatment of solid tumors; however, payload-driven toxicities may affect symptom burden, treatment continuity, and outcomes. Clinical trials are often underpowered to detect delayed or multisystem adverse events and may not reflect real-world popu...

Z. Sarfraz, Tanay Venkat Malla, Ayush Patel et al. · 0 citations
Review Open access Aug 2026

SADA-18 BRACHYTHERAPY FOR RECURRENT BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OUTCOMES

In patients with recurrent BM, intracranial brachytherapy is associated with high rates of local control, supporting its role as a focal salvage strategy in carefully selected patients and underscores the need for prospective studies to better define patient selection and optimize integration with novel systemic therap...

Ruchit P. Jain, Namita Ruhela, K. Qidwai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.